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Summary  33	
 34	
The development of new approaches is critical to gain further insights into biological processes 35	
that cannot be obtained by existing methods or technologies. The detection of protein-protein 36	
interaction is often challenging, especially for weak and transient interactions or for membrane 37	
proteins. Over the last decade, several proximity-tagging methodologies have been developed 38	
to explore protein interactions in living cells. Among those, the most efficient are based on 39	
protein partner modification, such as biotinylation or pupylation. Such technologies are based 40	
on engineered variants of enzymes like peroxidases or ligases that release reactive molecules, 41	
in the presence of specific substrates, that bind surrounding proteins. Fusing a protein of interest 42	
to these enzymes allows the definition of an unbiased “proxisome”, that is all of the proteins in 43	
interaction or in close vicinity of the protein of interest. Here, I describe the different proximity-44	
labeling tools available and provide a comprehensive comparison to discuss advantages and 45	
limitations. 46	
 47	
 48	
 49	
 50	
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 53	
 54	
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1. Introduction 57	
By analogy with a theater play, biological processes require different actors assigned to perform 58	
specific tasks in space and time. In living cells, such actors are mostly proteins that 59	
“communicate” between each other. Communication is achieved through different types of 60	
interactions such as weak, transient, stable or long interactions, resulting in specific biological 61	
effects. Protein-protein interaction (PPI) can lead to conformational effects which enable the 62	
formation of a structural complex, activate or inactivate a protein, create a new biding site for 63	
the interaction with other binding partners or a substrate, serve as regulatory pathway, or allow 64	
subcellular relocalization.  65	
Detection of PPIs, in space and time, is therefore critical for deciphering each step of a 66	
biological process. A number of methods for assaying PPIs in vivo have been developed and 67	
are routinely used in laboratories. Co-immunoprecipitation (Co-IP) represents one of the most 68	
standard methods of identifying interacting partners in vivo[1,2]. Briefly, a protein of interest 69	
(POI) is immunoprecipitated from a cellular protein extract by using specific antibodies 70	
immobilized on beads (Fig. 1a). While unbound proteins are washed out, binding partners are 71	
co-precipitated and can be visualized and identified by Western Blot or mass spectrometry 72	
analysis. It is worthy to note that Co-IP is a variant of the pull-down assay, which used a tagged 73	
bait protein to capture protein complexes instead of antibodies. Tandem affinity purification 74	
(TAP) is also a systematic approach to detect PPIs at near proteome-scale under in vivo 75	
conditions. TAP consists in two consecutive purifications by using two different tags fused to 76	
a bait protein, then considerably reducing the amount of nonspecific contaminants[3,4]. 77	
Additional methods such as two-hybrid systems, including bacterial (BACTH) and yeast (Y2H) 78	
two-hybrid assays (see[5] for comparative review), are powerful genetic approaches to 79	
characterize PPIs in native or near-native context[6–13]. POIs are fused to the two isolated 80	
fragments from the Bordetella pertussis adenylate cyclase[6,8–10,13] or from the Gal4 81	
transcription factor[7,11,12] for BACTH and Y2H respectively (Fig. 1b). Physical association 82	
between tested proteins pairs restores the activity of the adenylate cyclase or Gal4 that can be 83	
visualized by a transcriptional-activated reporter. Other interaction-mediated reconstitution-84	
based methods exist, such as the TOXCAT or GALLEX systems for studying transmembrane 85	
helix-helix oligomerization in a natural membrane environment[14–16]. With a similar conceptual 86	
approach, Förster resonance energy transfer (FRET) is a well-suited biophysical method for the 87	
investigation of PPIs that occur between two proteins positioned within 10 nanometers of each 88	
other, allowing study of molecular interactions in real time[17,18]. In brief, FRET relies on the 89	
energy transfer from a donor fluorescent molecule (i.e., diminution of fluorescence intensity) 90	
to an acceptor when these two probes are separated by 10 nanometers or less [19–22] (Fig. 1c). 91	
Then, PPIs or conformational changes within a protein (if the two probes are fused to the same 92	
protein) can be visualized in real time, by using a fluorometer or a fluorescence microscope. 93	
Furthermore, this method can be extend to several practical applications in biology such as the 94	
detection of protein cleavage, changes in micro-environment or quantitative analysis of protein 95	
interactions (see[23,24] for comprehensive reviews).  96	
Although these methods have improved our knowledge about biological processes by the 97	
characterization of number of PPIs, some important limitations are still present. Due to the 98	
nature of stringent purifications, co-precipitation based-methods (i.e., Co-IP, pull down and 99	
TAP) are not reliable to detect weak or transient PPIs, leading to a lot of false negatives[25]. In 100	
two-hybrid systems, proteins are produced from multi-copy plasmids and not at the 101	
physiological concentration in the cell, which may cause unbalanced stoichiometry and effects 102	
on PPIs, or toxicity within the cell[26]. Proper re-assembly of the reporter is dependent of the 103	
spatial association between the two tested proteins, hence steric effects may occur and prevent 104	
detection of PPI. Screening only soluble domains of membrane proteins, which need the cell 105	
membrane for proper folding, can lead to false negative in PPIs. Further, bait and prey proteins 106	
are artificially put into the same subcellular compartment (i.e., the bacterial cytosol or the yeast 107	
nucleus for BACTH and Y2H respectively), which may be different from the native 108	
compartment of the POIs. Hence, protein pair could interact in a compartment where they 109	
normally may not encounter each other or not interact if the physicochemical conditions are too 110	
different from the native compartment(s). Finally, fluorescence based-methods suffer from 111	
inherent physical and technical limitations. In FRET, since the distance between the donor and 112	
the acceptor must be within the Förster radius (i.e., ~10 nm), poor positioning of fluorescent 113	
probes in protein pair might lead to defect in detection of PPI.  In addition, spectral leakage, 114	
that correspond to the direct excitation of the acceptor and causing false positive detections, 115	
donor fluorescence background, photobleaching and trouble for measurements make real PPI 116	
detection quite difficult[27].  117	
Deciphering subtle PPIs in living cells is a challenge that cannot be achieved by those 118	
conventional methods. Detection of weak and transient interactions, which constitute the major 119	
part of PPIs in dynamic processes, interactions with membrane proteins and more importantly, 120	
the detection in true in vivo context (i.e., both in native cell and at the chromosomal expression 121	
level) must be improved to understand the complexity of biological processes. Over the last 122	
decade, proximity-tagging approaches have been developed to explore these questions. Based 123	
on protein partner modifications, proximity-tagging methodologies allow the definition of an 124	
unbiased “proxisome”, that is all of the proteins in direct interaction or in close vicinity of the 125	
POI, in native conditions and without loss of elusive PPIs. Currently, three major proximity-126	
tagging approaches are used: the proximity-dependent biotin identification (BioID), the APEX 127	
proximity-dependent biotin labeling and the recent pupylation-based interaction tagging (PUP-128	
IT). Here, I detail the principles of these proximity-tagging methodologies and their different 129	
applications in biology. Finally, I provide a comprehensive comparison to allow the definition 130	
of the most appropriate approach for your studies. 131	
2. Proximity-dependent biotin identification (BioID)  132	
BioID is a useful proximity-dependent labeling method to screen both interacting and 133	
neighboring proteins in their in vivo context. BioID assay is based on the promiscuous 134	
biotinylation generated by a modified variant of BirA[28,29]. BirA is a 35-kDa bacterial biotin 135	
ligase that catalyzes the biotinylation of BCCP, a subunit of the acetyl-CoA carboxylase in 136	
Escherichia coli[30,31]. By using endogenous biotin and ATP, BirA produces biotinoyl-5’-AMP 137	
molecules and biotinylates BCCP with an exquisite specificity. To perform proximity-138	
dependent labeling, the R118G mutant BirA protein (BirAR118G or BioID protein) is used. This 139	
variant, which normally binds ATP, displays a low affinity for biotinoyl-5’-AMP compared to 140	
the WT BirA[32]. Hence, biotinoyl-5’-AMP molecules are released from BioID protein and 141	
covalently react with proximate proteins, and specifically on lysine residues, in a range of 142	
approximately 10 nm[33,34]. For BioID assay, promiscuous biotinylation is induced in cells 143	
producing BioID fusion protein by adding a supraphysiological concentration of biotin in the 144	
medium during an optimal labeling period of 16-18h[34–36] (Fig. 2). Biotinylated proteins, which 145	
are candidate interactors for the POI, are then enriched on streptavidin beads and identified by 146	
mass spectrometry.  147	
Recently, significant efforts have been made to improve BioID assay in living cells. Screen for 148	
substitutions in the biotin binding site that modulate BirA activity revealed that R118K 149	
substitution reduced biotin affinity and increased the biotinoyl-5’-AMP release[37]. In 2016, 150	
Kim and colleagues tested the potential of BirA protein from the thermophilic bacterium 151	
Aquifex aeolicus[38]. This variant, called BioID2, is 8-kDa smaller than BioID (i.e., 27 kDa) and 152	
requires less biotin supplementation for proximity labeling[38]. Interestingly, assaying for 153	
dimerization-dependent protein interactions was investigated by split-BioID, where inactive 154	
BioID-fragment complementation pair was generated as split-reporter and forms a functional 155	
BioID protein that biotinylates substrates and other proximate proteins upon 156	
heterodimerization[39]. Finally, by using yeast display-based directed evolution, the Ting lab 157	
recently engineered two enhanced BioID variants: the 35-kDa TurboID and the 28-kDa 158	
miniTurbo[40]. These variants display a remarkable labeling power, dropping from 16-18h to 159	
only 10 min labeling period with similar size and specificity than standard BioID[40]. 160	
Furthermore, proximity labeling activity of TurboID and miniTurbo is conserved in different 161	
ranges of pH and at low temperature[40] by contrast to BioID and BioID2 proteins[38]. Taken 162	
together, such improvements greatly extended the potentiality of the BioID system for assaying 163	
proxisome detection in plethora of contexts. 164	
BioID was initially developed for the study of the in vivo nuclear lamin-A proxisome in 165	
mammalian cells[34]. Up to now, BioID has been successfully used in diverse contexts. In 166	
mammalian cells, BioID was applied to probe architecture of different subcellular locations 167	
such as the nuclear pore complex[33,41,42], focal adhesion complexes[43] or the centrosome-cilium 168	
interface[44], and also to get insights about molecular mechanisms such as mitochondrial 169	
proteostasis[45,46], autophagy[47], mitosis [48–50] or viral infection[51]. BioID was also elegantly 170	
adapted to investigate RNA-protein interactions that play important roles in cellular functions 171	
and diseases. Named RaPID (for RNA–protein interaction detection), this method enables the 172	
detection of proteins which interact with a specific RNA[52]. Briefly, the RNA of interest is 173	
flanked by bacteriophage BoxB stem loops which bind by the lN peptide with high affinity[53]. 174	
The lN peptide is fused to the N-terminus of BioID protein. Then, BoxB stem loops recruit the 175	
lN-BioID fusion protein and thereby biotinylating proteins bound to the RNA of interest in 176	
living cells[52]. In addition, authors engineered BASU, a modified biotin ligase from Bacillus 177	
subtilis that displays faster kinetics (>1000-fold) and increased signal-to-noise ratio (>30-fold) 178	
compared to the standard Escherichia coli BioID protein. Although less active than miniTurbo 179	
and TurboID[40], BASU enabled sufficient labeling of proteins for RaPID study in living 180	
cells[52]. Finally, BioID was used for proximity labeling in planta[54,55] and directly on animals 181	
such as in mouse[56] and recently in fruit flies (Drosophila melanogaster) and worms 182	
(Caenorhabditis elegans)[40]. 183	
3. APEX proximity-dependent biotin labeling 184	
APEX is a spatially resolved proteomic mapping assay to determine in vivo proxisome in 185	
dynamic systems in living cells. By contrast to BioID, APEX-dependent labeling is based on 186	
the activity of the engineered enhanced hemic ascorbate peroxidase APEX, a 27-kDa 187	
monomeric derivative of protein from soybean[57,58]. Briefly, APEX catalyzes the H2O2-188	
dependent oxidation of phenol derivatives (the biotin-phenol, BP, being the most specific 189	
substrate for APEX) into short lived phenoxyl radicals (<1 ms) that covalently react in a small 190	
labeling radius (<20 nm) with electron-rich amino acids such as Tyr, Trp, His and Cys[58]. It 191	
has been recently established that tyrosine residues are the principal site of biotinylation by 192	
APEX with more than 98 % labeling observed[59]. Similar to BioID workflow, APEX labeling 193	
starts with the construction of a functional fusion between APEX and the POI. After incubation 194	
with BP, cells producing APEX fusion are treated with a 1-min pulse of hydrogen peroxide 195	
enabling APEX-dependent biotinylation of proximate proteins in a short labeling radius (Fig. 196	
3)[58,60]. Subsequently, cells are lysed and biotinylated proteins are purified and identified by 197	
mass spectrometry analysis.  198	
Due to its low activity when expressed at physiological level, APEX protein was further 199	
improved to enhance its sensibility in living cells. By using directed evolution, a single point 200	
substitution (A134P), located in a loop at the vicinity of both heme and the aromatic substrate–201	
binding site was found to confer great improvements in stability, kinetics, heme binding and 202	
resistance to high H2O2 concentrations[61]. Named APEX2, this variant is much more active 203	
than APEX in the cell and is consequently better for proteomic mapping[61]. Very recently, a 204	
split-APEX (sAPEX) system has been developed[62]. Two fragments called “AP” (a 200-amino-205	
acid N-terminal fragment) and “EX” (a 50-amino-acid C-terminal fragment) are each inactive 206	
but give peroxidase activity upon reconstitution. Authors proposed that the sAPEX system 207	
could be useful to address question about interaction-dependent proximity labeling at higher 208	
spatiotemporal resolution. Hence, sAPEX reconstitution can be applied for mapping 209	
specifically proxisome of target nucleic acids (e.g., mRNA, non-coding RNA or genomic locus) 210	
by considerably reducing background caused by the activity of APEX2 that is not bound to the 211	
target of interest[63,64], or to capture molecular composition at the interface of two organellar 212	
structures such as at mitochondria-ER contact[62]. 213	
Over the past 6 years, many applications of APEX labeling have emerged to map proxisome 214	
within specific locations and/or in dynamic molecular processes. Extensively used in eukaryotic 215	
cells, APEX has been applied for investigating complex proteomes such as in human or in 216	
Drosophila melanogaster mitochondria[58,60,61,65–67], in mammalian cilia[68] or in yeast Golgi[69]. 217	
APEX proximity biotinylation was also used for exploring dynamic macromolecular complexes 218	
within specific genomic loci or for RNA subcellular location. In order to define the human 219	
mitochondrial nucleoid proteome, fusion between APEX2 and the mitochondrial DNA helicase 220	
Twinkle was constructed and revealed new nucleoid-associated proteins[70]. Last year, two 221	
independent groups reported the development of GLoPro (for genomic locus proteomics) and 222	
C-BERST (for dCas9 biotinylation at genomic elements by restricted spatial tagging), a 223	
combination of CRISPR-based genome targeting with APEX2-dependent proximity labeling 224	
for defining proteome at specific genomic locus[63,64]. While receptor signaling constitutes a 225	
critical process involved in numerous physiological regulations, tracking those processes 226	
requires high spatio-temporal resolution and high throughput, missing in current methods. 227	
Back-to-back papers from Kruse and Krogan labs elegantly demonstrated the application of 228	
APEX assay to G-protein-coupled receptors signaling by tracking interactions at several 229	
different time points upon addition of activating ligand and within a native cellular 230	
environment[71,72]. They finally concluded that APEX is a powerful method for spatially 231	
resolved quantitative analysis of signaling, applicable to any other signal transduction 232	
monitoring[71,72]. Designed at the beginning for proteomic mapping, APEX has been recently 233	
used for transcriptomic mapping assay. Spatial organization of RNA within the cell has been at 234	
first determined by an indirect approach combining APEX proximity labeling with RNA-235	
protein chemical crosslinking[73]. As this approach was inadequate for spatial specificity in 236	
unenclosed cellular locations, authors introduced APEX-seq, a direct APEX-catalyzed labeling 237	
of RNA combined with RNA-seq. This direct approach was successfully used in nine distinct 238	
subcellular compartments allowing determination of a the RNA atlas in human cell[74] and 239	
recently the organization of translation initiation complexes[75]. Finally, Zhou and colleagues 240	
recently developed promising biotin-aniline and biotin-naphthylamine probes (Btn-An and Btn-241	
Nap, respectively), a new class of phenolic compounds with significantly higher reactivity 242	
towards nucleic acids[76]. Such developments open the field of new broad applications for in 243	
situ transcriptomic assay to shed light on RNA functions in cell physiology.  244	
Over the last year, APEX biotinylation assay was also performed in different microbial 245	
pathogens such as for the mapping of the inclusion membrane proteins in Chlamydia 246	
trachomatis[77–80], in Mycobacterium smegmatis periplam[81], in the diplomonad fish parasite 247	
Spironucleus salmonicida[82], and in enteroaggregative Escherichia coli where stage-blocking 248	
mutations were used to define in vivo temporal contacts of the TssA protein during type VI 249	
secretion system biogenesis[83]. With its broad range of applications in diverse organisms and 250	
for labeling of different types of macromolecules, APEX proximity-dependent biotin labeling 251	
constitutes a powerful tool for cellular processes that require high spatial specificity and short 252	
labeling windows. 253	
4. Pupylation-based interaction tagging (PUP-IT) 254	
As a new proximity tagging method, the PUP-IT system was developed from the ubiquitin-like 255	
process present in actinobacteria[84–86]. The pupylation-based modification was extensively 256	
studied in Mycobacterium tuberculosis for its implication in bacterial proteasome, a cellular 257	
system required for causing disease[85,87,88]. In this system, the Pup ligase PafA uses ATP to 258	
transfer an activated Pup(E) substrate to a lysine of a target protein[85,89,90]. Thereafter, the 259	
Pup(E)-protein complex is targeted to the mycobacterial proteasome for unfolding and 260	
degradation[85,90,91]. Taking advantage of this system, Liu and colleagues adapted the Pup 261	
system from Corynebacterium glutamicum as a PUP-IT tool to define membrane and 262	
intercellular PPI[92]. They first determined the potential of PafA to be a suitable proximity-263	
tagging enzyme and revealed that compared to BioID and APEX substrate, activated Pup(E) 264	
does not freely diffuse from PafA, suggesting that very close proximity between the bait protein 265	
and their partners is required for proper pupylation. They then tested in vivo PUP-IT by fusing 266	
PafA to the membrane receptor CD28 to identify its cytosolic tail interactome (Fig. 4a). By 267	
inducing the production of a biotinylated carboxylase-fused Pup(E) protein (bio-Pup(E)), which 268	
was under the control of the locked TET-ON system[93], the authors initiated the pupylation-269	
based labeling and successfully enriched known CD28-interacting proteins such as ITK, p85 or 270	
LCK[92]. They finally explored the possibility of extracellular PUP-IT labeling. To avoid long 271	
exposure of PafA at the cell surface, authors induced the external heterodimerization of CD28 272	
and PafA by using the FKBP-rapamycin-FRB system[94] (Fig. 4b). Upon reconstitution, the 273	
addition of ATP and truncated biotin-fused Pup(E) DE28 peptides (bio-DE28) enabled cell 274	
surface labeling suggesting that PUP-IT can be used for extracellular pupylation[92].  While the 275	
PUP-IT has been only used in this study, it represents a promising method for assaying in vivo 276	
PPIs especially involved in cell-to-cell communication, cell-to-cell adhesion, or host-pathogen 277	
interactions.  278	
5. What is the best approach (for you)?  279	
Proximity-tagging methods can be used to circumvent inherent technical limitations that 280	
conventional approaches for assaying in vivo PPIs suffer from. However, each of them display 281	
differences which are both important or not depending on the nature of the study. In this section, 282	
I will compare the specifications of each method to help defining the most suitable approach 283	
for your studies. 284	
5.1. Advantages compared to conventional methods 285	
As mentioned in the introduction, proximity-tagging methods present many benefits compared 286	
to conventional methods. First, interactome/proxisome of a POI can be defined under native 287	
expression and stoichiometry by fusing tagging enzyme-coding gene at chromosomal locus of 288	
the bait POI. Because proximate proteins are covalently labeled before purification, transient, 289	
weak or hydrophobic interactions, which are lacking from some conventional methods, can be 290	
easily detected. Further, promiscuous labeling of non-interacting-proximate proteins might be 291	
useful to understand the environment of the POI and hence, to get new insights about its role 292	
and/or its subcellular location in the cell. Interestingly, it has been shown that proxisome can 293	
be expanded or reduced by modifying the length of the linker between the bait and the tagging 294	
protein[38]. As previously described, labeling molecules (i.e., biotinoyl-5’-AMP for BioID, 295	
biotin-phenoxyls for APEX and Pup(E) for PUP-IT) have been shown not to cross plasma 296	
membrane[34,58,92], therefore proteome definition into cellular organelle or near to the membrane 297	
might be useful to determine topology of transmembrane proteins[58,67,95]. Finally, the use of 298	
proximity-tagging methods in several biological contexts, ranging from the bacterial cell to the 299	
living animals, makes them powerful versatile tools for investigating endogenous PPIs. 300	
5.2. Common features to keep in mind before starting 301	
As biological applications, proximity-tagging methods can be limited or be not suitable in 302	
specific context. 303	
First, characterization of the bait protein is a basic, but important prerequisite to confirm that 304	
its location and its function in the cell are conserved in fusion with the tagging enzyme. Hence, 305	
the use of proximity labeling method without preliminary results about the POI is strongly 306	
discouraged.  307	
While biotin is commonly used for detection and enrichment, it is necessary to examine 308	
endogenous biotinylation occurring in your model organism. Overrepresentation of endogenous 309	
biotinylated proteins might be detrimental by preventing enrichment of proximity labeled-310	
proteins, especially if the POI is thought to have only few partners. For example, in 311	
Mycobacterium smegmatis, APEX2-dependent biotinylated proteins were confounded by 312	
endogenous biotinylated proteins[81]. To address this problem, authors successfully designed 313	
two alternative labeling molecules: tyramide alkyne and tyramide azide, which can be used both 314	
for detection and enrichment via a copper-catalyzed alkyne/azide cycloaddition “click” 315	
reaction[81]. Thus, the design of new probes could be a good option to circumvent this type of 316	
issue in specific organisms.  317	
Proximity labeling is associated with the presence and the accessibility of reactive residues such 318	
as lysine in BioID[28,34] and PUP-IT[92] assay, and mostly tyrosine in APEX proximity-319	
labeling[58,59].  Consequently, the efficiency of labeling is dictated by the composition and the 320	
folding of proximate proteins. The absence of labeling does not therefore means a lack of 321	
interacting or proximity partners, especially for proteins that lack of exposed Tyr/Lys. By 322	
contrast, abundance of biotinylated proteins cannot be used to quantitatively assess the presence 323	
or the strength of a putative interaction.  324	
Except for PUP-IT system that requires contact for labeling[92], labeling radius in BioID and 325	
APEX assay is not a fixed value but instead a “cloud” or a “labeling gradient” where contours 326	
depend on the physicochemical micro-conditions such as temperature or pH[28,60]. By defining 327	
a “proxisome”, it could be necessary to determine whether identified biotinylated proteins are 328	
in direct interaction or in close proximity of the POI, especially if the POI is included within a 329	
multiprotein complex.  330	
Although weak, labeling of endogenous proteins present at many nanometers away from 331	
tagging enzyme might be detected by MS analysis, especially in non-membrane-enclosed 332	
cellular regions. Hence, efficient discrimination from proximate biotinylated proteins to the 333	
cellular background is essential. To address this question, most studies combined proximity-334	
tagging methods with quantitative proteomics such as stable isotope labeling by amino acids in 335	
cell culture[43,60,63,66,95–97] (SILAC), tandem mass tagging[64,70] (TMT), or label-free 336	
quantification[92] (LFQ). Schematic pipelines of these approaches applied to proximity-tagging 337	
methods are represented in Fig. 5. Although there is no any report for preferentially using one 338	
approach compared to another in the proximity-dependent labeling context, technical 339	
specifications should be considered before starting your study. For example, SILAC and TMT 340	
are much more expensive than LFQ but are more accurate for proteomic quantification. 341	
Because LFQ is a non-ratiometric approach, there is no limit in multiplexing (i.e., the number 342	
of conditions that can be tested simultaneously) by contrast to SILAC and TMT, limited to 5-343	
plex and 10-plex respectively. SILAC requires metabolically active cells to incorporate labels 344	
whereas TMT can be directly performed on extracted peptides. Still, while LFQ presents a 345	
better proteome coverage, it requires significantly longer data acquisition time compared to 346	
SILAC or TMT. For the choice of the most suitable quantitative approach, see[98] for recent 347	
comprehensive comparison.  348	
5.3. Comparative of the three approaches  349	
To discriminate among those proximity-tagging methods, comparison of the main features 350	
could be important for specific biological studies. In this context, I decided to distinguish 351	
TurboID/miniTurbo assay (hereafter, (mini)TurboID assay) from BioID assay due to striking 352	
differences in labeling process. All of the data are summarized in Table 1.  353	
APEX2, BioID2 and miniTurbo are relatively small proteins with a molecular mass of about 354	
27 kDa[38,40,58,61] while Turbo-ID, BioID and PafA proteins are larger, with a molecular mass 355	
of about 35 kDa[40], 35 kDa[34] and 54 kDa[92] respectively. Because the tagging-enzyme is fused 356	
to the bait protein, its molecular mass can affect the localization and/or the function of the bait 357	
protein in the cell. Thus, preliminary results about your POI can be useful to wisely determine 358	
where you have to fuse the tagging-enzyme (i.e., in N or C-terminus of the POI), the nature of 359	
the linker, in terms of residues and length, and the most suitable enzyme.  360	
In BioID and (mini)TurboID assays, tagging-enzyme uses native ATP and exogenous input of 361	
biotin as substrates for proximity labeling[34,40]. Since biotin is essential for life, its 362	
incorporation in cells is ensured by specialized transporters[99]. By contrast, APEX2 uses H2O2 363	
and non-natural phenol derivatives as substrates[58,76,81]. Although in mammalian cells no 364	
specific treatment is used for biotin-phenol incorporation, it has been reported that cell 365	
permeability can limit biotin-phenol incorporation in yeast, preventing efficient labeling[69]. In 366	
E. coli, biotin-phenol uptake is in part mediated by the major g-proteobacterium biotin 367	
transporter YigM (Santin et al., unpublished data). Therefore, biotin-phenol incorporation 368	
requires optimization for each organism. Finally, as non-natural compounds, whether phenol 369	
derivatives affect cell growth needs to be examined for each case. During labeling, H2O2 370	
treatment could affect the general cell oxidative state and cause cellular stress. Hence, APEX 371	
assay is perhaps not suited for studies applied to oxidative stress or protein repair. In PUP-IT 372	
assay, as Pup(E) derivative-peptides are not commercially available[92], purification of these 373	
substrates for extracellular labeling could be a limitation. However, Pup(E) substrates can be 374	
genetically expressed in cells, and hence PUP-IT assay might be useful in organisms in which 375	
substrate uptake is limiting.   376	
To perform efficient in vivo labeling, the temperature in which the tagging-enzyme is active 377	
has to fit with the growth temperature of the studied organism. In contrast to the BioID protein 378	
that has an optimal temperature of 37°C[34,38], BioID2 protein has optimal activity of 50°C, 379	
yielding this enzyme well suitable for labeling in thermophilic conditions[38]. Whereas BioID2 380	
retains highly efficient biotinylation at 37°C, both BioID and BioID2 proteins exhibit reduced 381	
activity below 37ºC[38]. APEX2, miniTurbo and TurboID proteins have an optimal activity at 382	
37°C. Because these proteins were evolved from directed evolution in yeast (growing at 30°C), 383	
they retain high activity at 30°C[40,61]. In addition, miniTurbo and TurboID have been 384	
successfully used in worms and flies which grow at 20°C and 25°C, respectively. While PafA 385	
has only been tested in mammalian cells[92] (37°C), the range of temperatures in which it retains 386	
its activity has to be determined. 387	
An important aspect of the proximity labeling is the temporal resolution of the reaction, both in 388	
the control of the labeling initiation and in the labeling time. For example, definition of 389	
signaling networks upon ligand-induced activation requires high temporal resolution[71,72] in 390	
contrast to studies about proteome definition in specific subcellular locations[33,41,44,58,60,65,67]. 391	
In BioID and (mini)TurboID assays, the enzyme is active just upon translation and can use 392	
endogenous biotin and ATP for proximity labeling, even before correct localization of the 393	
fusion protein[34,40]. In the PUP-IT assay, even though Pup(E) expression might be monitored, 394	
invariable delay exists between induction and PafA mediated-pupylation[92]. Hence, the 395	
initiation of the labeling process may not be precisely controlled in these approaches. Finally, 396	
as APEX-proximity labeling is nearly instant[58,60,61], temporal control of the labeling can be 397	
achieved by addition of H2O2 in the culture at specific time points. APEX assay is therefore 398	
perfectly suited for taking snapshots of PPIs, for example in cellular response upon 399	
environmental changes[71,72] or during assembly of macromolecular complexes[83]. With slow 400	
tagging kinetics, the BioID and PUP-IT assays require 16-18 hours or 24-36 hours of labeling 401	
time for efficient biotinylation/pupylation, respectively[34,92]. These approaches are hence not 402	
suited for capturing transient protein interactions but rather provide a history of protein 403	
associations over long periods of time, as used in cell cycle[48–50] or in viral infection[51]. 404	
TurboID and miniTurbo were designed to improve BioID assay by reducing the labeling time 405	
from 16-18 hours to 10 minutes[40]. However, recent studies showed that this time might be 406	
adapted depending on the organism studied. While 10 min are sufficient in mammalian cells[40], 407	
TurboID-mediated biotinylation requires about 30 minutes to 3 hours in yeast[100], 4 hours in 408	
flies[40], 4 hours to several days in worms[40] and 12 hours in plants[101]. Optimization of the 409	
TurboID labeling time should therefore be done for each organism, especially to prevent 410	
toxicity via chronic endogenous biotinylation or endogenous biotin consumption due to the 411	
high activity of these enzymes[40]. 412	
Finally, BioID and (mini)TurboID assays have never been tested for extracellular labeling by 413	
contrast to APEX[102] and PUP-IT[92]. Nevertheless, as PUP-IT and BioID-derivative assays use 414	
a similar combination of ATP and substrates (Pup(E) and biotin, respectively), there is no 415	
reason why BioID and (mini)TurboID should not work for extracellular labeling.  416	
6. Conclusions and prospects  417	
In molecular biology, the major question is: who acts in that process? To address this question, 418	
many PPI-assaying methodologies have been designed for decades. However, technical 419	
limitations in detection of PPIs in living cells, such as weak, transient or hydrophobic 420	
interactions, prevent global comprehension. By providing both in vivo spatiotemporal 421	
information and high-throughput analysis, proximity-tagging methods represent the next 422	
generation of in vivo PPIs assay. In addition to the major proximity-tagging methods presented 423	
in this review, other technologies exist including for example horseradish peroxidase-424	
dependent labeling approaches (EMARS[103,104] and SPPLAT[105–107]), photoactivated in vivo 425	
proximity labeling[108], NEDDylator system[109,110] and methylation-based chromatin profiling 426	
approach DamID[111,112]. While proximity-tagging methods have been used in a variety of 427	
biological contexts, further challenges remain to be overcome. For example, in thermophilic 428	
organisms, such as archaea, where tools available for PPIs assay are limited[113], or in protein-429	
lipid interactions, involved in many diseases including cancer, obesity, neurodegenerative 430	
disorders or cardiovascular pathologies[114]. However, over the last decade, the rapid 431	
development of these proximity-tagging methods, in specificity and spatio-temporal control, 432	
has revealed their potential to answer deeply questions in molecular biology. One may assume 433	
that other applications will be made in the near future to further unravel the molecular 434	
complexity in living cells. 435	
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 655	
Legend to Figures 656	
Figure 1. Schematic representation of conventional methods used for detection of PPIs. a) Co-657	
immunoprecipitation workflow. From left to right: cellular proteins are extracted from cells and 658	
incubated with specific antibody-coated beads directed against a protein of interest (green). The 659	
protein of interest and its direct (blue) and indirect (yellow) partners are then co-660	
immunoprecipitated. Detection of PPIs is achieved by Western Blot analysis (Total, total 661	
proteins in cellular extract; Co-IP, partners co-immunoprecipitated with the protein of interest) 662	
b) Two-hybrid assay. Two-hybrid assay is based on the reconstitution of a specific protein 663	
(adenylate cyclase for BACTH and Gal4 for Y2H) that consists in two domains (light and dark 664	
grey). Bait (in green) and prey (in blue or red) proteins are translationally fused to isolated 665	
domains. Spatial association between bait and prey proteins restores the proximity of the two 666	
domains and then the protein activity, leading in fine to the transcription of a reporter gene. c) 667	
FRET assay. A bait (in green) and a prey (in blue or red) protein are translationally fused in 668	
tandem to fluorescent proteins. An example is showed with the cyan fluorescent protein (CFP, 669	
cyan) and the yellow fluorescent protein (YFP, yellow). Energy transfer (i.e., FRET) between 670	
fluorescent reporters can occur if the bait and the prey proteins are within 10 nm of distance 671	
(left panel). The loss of fluorescence intensity from the donor (CFP) and the increase of 672	
fluorescence intensity from the acceptor (YFP) can be visualized by monitoring fluorescence 673	
spectra (right panel). 674	
 675	
Figure 2. BioID workflow. Fusion between BioID protein (blue) and a bait protein (black) is 676	
expressed in native context within cells. In vivo labeling (blue radius) is initiated by the addition 677	
of a supra-physiological concentration of biotin during many hours. Cells are then lysed, and 678	
biotinylated proteins are purified by enrichment on streptavidin beads. Trypsin digestion 679	
provides the generation of peptides that are then identified by mass spectrometry. 680	
 681	
Figure 3. APEX proximity-dependent biotin labeling workflow. Fusion between APEX2 682	
protein (blue) and a bait protein (black) is expressed in native context within cells. After 683	
incubation in presence of biotin-phenol, a H2O2 pulse allows biotin labeling (red radius) of both 684	
direct partners (yellow and green) and proteins in close environment of the bait protein (brown). 685	
While unbiotinylated proteins are washed, biotinylated proteins are purified by enrichment on 686	
streptavidin beads after cell lysis. Trypsin digestion provides the generation of peptides that are 687	
then identified by mass spectrometry. 688	
 689	
Figure 4. PUP-IT workflow for intra and extracellular labeling. a) For intracellular labeling, 690	
the cytosolic domain of the membrane receptor CD28 (blue) is fused to the PUP ligase PafA 691	
(green). The expression of the bio-Pup(E) substrate is under the control of TET-ON system. 692	
Addition of doxycycline (Dox) induces bio-Pup(E) production and initiates the PafA-mediated 693	
labeling (green radius). b) For cell surface labeling, the extracellular domain of the membrane 694	
receptor CD28 (blue) and PafA (green) are fused to specific adaptors, FKBP and FRB, 695	
respectively. Addition of rapamycin (purple pill) allows the link between the two adaptors and 696	
hence, the formation of a functional PUP-IT complex. PafA-mediated labeling (green radius) 697	
is initiated upon the addition of ATP and truncated bio-Pup(E) peptides (bio-DE28). 698	
 699	
Figure 5. Schematic pipelines for major quantitative approaches used for proximity-tagging 700	
quantification. For each approach, 1 corresponds to the negative control (without tagging 701	
enzyme), 2 corresponds to the specificity control (where the tagging enzyme is independently 702	
expressed in the same cellular compartment that the bait protein), and 3 corresponds to the test 703	
(the bait protein is fused to the tagging enzyme). a) Three-state SILAC experiment. Cells are 704	
grown in presence of light (L, yellow, negative control), medium (M, blue, specificity control) 705	
or heavy (H, red, test) stable isotope–enriched amino acids. Upon proximity labeling, L, M and 706	
H protein extracts are combined at equal ratio before further processing. Biotinylated proteins 707	
are then enriched, digested and quantified by LC-MS/MS analysis. In this case, H/L intensity 708	
ratio represents the extent of biotinylation by the tagging enzyme and H/M intensity ratio 709	
represents the extent of specific biotinylation by the tagging enzyme versus non-specific 710	
endogenous proteins. b) Triplex TMT experiment. Cells are grown in standard conditions. 711	
Upon proximity labeling, biotinylated proteins are enriched, digested and then chemically 712	
tagged with MS-differentiable TMT labels (126, red, negative control; 127, blue, specificity 713	
control; 128, green, test). Tagged-peptides are combined at equal ratio and quantified by LC-714	
MS/MS analysis. 128/126 intensity ratio is used to distinguish the extent of biotinylation by the 715	
tagging enzyme and 128/127 intensity ratio represents the extent of specific biotinylation by 716	
the tagging enzyme versus non-specific endogenous proteins. c) LFQ assay. Cells are grown in 717	
standard conditions. Upon proximity labeling, biotinylated proteins are enriched and digested. 718	
Samples are then independently quantified and compared by using ion intensity or spectral 719	
counting (as represented). 720	 	721	
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Table 1.  Comparative table of the main features of the different proximity-tagging methods 
 
 BioID (mini)TurboID APEX PUP-IT 
Origin Bacteria 
(BirA from 
Escherichia 
coli) 
Bacteria 
(BirA from 
Escherichia coli) 
Plantae (APX from 
Glycine max) 
Bacteria 
(PafA from 
Corynebacterium 
glutamicum) 
Molecular mass  35 kDa (for 
BioID) 
27 kDa (for 
BioID2) 
28 kDa (for 
miniTurbo) 
35 kDa (for 
TurboID) 
27 kDa 54 kDa 
Substrates Biotin and ATP Biotin and ATP H2O2 and phenol 
derivative-
molecules  
Pup(E) 
derivative-
peptides and ATP 
Range of 
temperaturea 
37°C for BioID 
and 37°C to 
50°C for BioID2 
20°C to 37°C 30°C to 37°C 37°C 
Enzyme 
activityb (at 
37°C) 
+ +++ ++++ ++ 
Time of labeling 16-18 hours 10 min to several 
hours (depending 
on the organism) 
1 min 24-36 hours 
Labeling radius  10-15 nm 10-15 nm 20 nm  Very close 
contact 
Labeled 
macromolecules 
Proteins Proteins Proteins and 
nucleic acids 
Proteins 
Labeled residues Lys Lys Tyr (98%) and 
Trp, His, Cys (2%) 
for proteins; 
mostly guanosine 
for nucleic acids 
Lys 
Temporal 
control (labeling 
initiation) 
No No Yes  No 
Information 
about the POI 
Long history Intermediate Snapshot Long history 
a Enzyme works at these temperatures but temperatures between this range have not necessary 
been tested  
b ++++, strong activity; +++, very good activity; ++, good activity; +, weak activity 
